MADE IN CANADA VACCINE APPROVED FOR HUMAN TRIALS

摘要

A vaccine invented at the University of Guelph has been approved for human clinical trials by the U.S. Food and drug Administration (FDA). The Phase 1 clinical trial plan will utilize the cGMP ster-ile conjugated vaccine against Campylobacter jejuni-one of the leading bacterial causes of food-borne illness in the world.